These data highlight the heterogeneity of glucose metabolism in individual cancer cells, and clearly indicate that CSCs identified by ALDH activity or ALDH1 protein levels do not show reduced glucose uptake, but may instead show increases in these parameters in a cell-type specific manner. The gene discussed is LDHA; the disease is cancer.